论文部分内容阅读
作者于莫斯科给予密切接触血液或血液制品的215名医务工作者接种法国巴斯德研究所研制的06AI乙肝疫苗HEVAC(每ml含HBsAg5.34微克,福尔马林0.0048毫克,氢氧化铝0.325毫克),每次接种1毫升。预防乙型肝炎。对其效果进行免疫学和流行病学调查。作者随机选155名非HBsAg携带者和抗—HBs阴性的医务工作者为对照组。结果
The 215 medical workers who were given close contact with blood or blood products in Moscow were vaccinated with the 06AI hepatitis B vaccine HEVAC (5.34 μg HBsAg per ml, 0.0048 mg formalin and 0.325 mg aluminum hydroxide) developed by the Pasteur Institute in France. , Each vaccination 1 ml. Hepatitis B prevention. The effect of immunological and epidemiological investigations. The authors randomly selected 155 non-HBsAg carriers and anti-HBs negative medical workers as control group. result